Exova Group PLC Director/PDMR Shareholding (3911Q)

TIDMEXO

RNS Number : 3911Q

Exova Group PLC

29 November 2016

EXOVA GROUP PLC

Notification of transactions of Directors and PDMRs

On 28 November 2016, Paul Barry, a person discharging managerial responsibilities ("PDMR"), sold 29,389 ordinary shares of 1 pence each ("Shares") in Exova Group plc (the "Company") as set out in column 3 in order to discharge tax liabilities arising upon exercise of a bonus share award as set out in the Company's RNS announcement dated 24 November 2016.

 
  1. Name     2. Status    3. Number of Shares sold 
                              and price per Share 
-----------  ----------  ---------------------------- 
 Paul Barry   PDMR        29,389 at GBP1.84 per Share 
-----------  ----------  ---------------------------- 
 

Following the sale, Paul Barry's total shareholding in the capital of Exova Group plc is 60,511 ordinary shares, representing 0.02 per cent. of the voting share capital of Exova Group plc.

 
 1     Details of the person discharging managerial 
        responsibilities/person closely associated 
----  --------------------------------------------------------------------- 
 a)    Name                          Paul Barry 
----  ----------------------------  --------------------------------------- 
 2     Reason for the notification 
----  --------------------------------------------------------------------- 
 a)    Position/status               PDMR - Group Managing Director, 
                                      Industries 
----  ----------------------------  --------------------------------------- 
 b)    Initial notification          Initial notification 
        / Amendment 
----  ----------------------------  --------------------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  --------------------------------------------------------------------- 
 a)    Name                          Exova Group plc 
----  ----------------------------  --------------------------------------- 
 b)    LEI                           N/A 
----  ----------------------------  --------------------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  --------------------------------------------------------------------- 
 a)    Description                   Ordinary shares of 1p each 
        of the financial 
        instrument, 
        type of instrument 
                                      GB00BKY7HG11 
        Identification 
        code 
----  ----------------------------  --------------------------------------- 
 b)    Nature of                     Sale of shares in order to discharge 
        the transaction               tax liabilities arising upon 
                                      exercise of a bonus share award 
                                      as set out in the Company's 
                                      RNS announcement dated 24 November 
                                      2016. 
----  ----------------------------  --------------------------------------- 
 c)    Price(s) and                      Price(s)            Volume(s) 
        volume(s) 
----  ----------------------------  ------------------  ------------------- 
                                           1.84                29,389 
 ---------------------------------  ------------------  ------------------- 
 d)    Aggregated 
        information 
        - Aggregated                   N/A 
        volume 
        - Price 
----  ----------------------------  --------------------------------------- 
 e)    Date of the                   28 November 2016 
        transaction 
----  ----------------------------  --------------------------------------- 
 f)    Place of the                  London 
        transaction 
----  ----------------------------  --------------------------------------- 
 

This notification is made in accordance with Article 19 of the Market Abuse Regulation and the Disclosure and Transparency Rules.

For and on behalf of Exova Group plc

Date: 29 November 2016

Neil MacLennan

General Counsel & Company Secretary

Telephone: [phone]

About Exova

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 138 laboratories and offices in 33 countries and employs more than 4,300 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors ranging from Aerospace to Fire & Building Products; Oil & Gas and Industrials; Infrastructure & Environment; Automotive; and Health Sciences.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHUKONRNNAAURA

(END) Dow Jones Newswires

November 29, 2016 04:00 ET (09:00 GMT)